Biomarin Pharmaceutical reported $39.15M in EBIT for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -33651000 79.36M
Acorda Therapeutics ACOR:US $ -13890000 387K
Agios Pharmaceuticals AGIO:US $ -97640000 3.5M
Alnylam Pharmaceuticals ALNY:US $ -191686000 44.95M
Amgen AMGN:US $ 2176M 324M
Bayer BAYN:GR 2.28B 1.89B
Biogen BIIB:US $ 940.9M 409.4M
Biomarin Pharmaceutical BMRN:US $ 39.15M 9.82M
Bluebird Bio BLUE:US $ -100761000 19.58M
Gilead Sciences GILD:US $ 2029M 868M
Insmed INSM:US $ -100938000 513K
Intercept Pharmaceuticals ICPT:US $ -13363000 3.09M
IONIS PHARMACEUT IONS:US $ -85514000 28.01M
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ 54.7M 51.6M
Ptc Therapeutics PTCT:US $ -92362000 5.84M
Puma Biotechnology PBYI:US $ 12.06M 12.8M
Regeneron Pharmaceuticals REGN:US $ 1306.9M 20.3M
Sangamo Biosciences SGMO:US $ -45734000 473K
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Seattle Genetics SGEN:US $ -133111000 61K
Ultragenyx Pharmaceutical RARE:US $ -141593000 4.96M
United Therapeutics UTHR:US $ 201.8M 86.2M
Vertex Pharmaceuticals VRTX:US $ 1119.3M 85.9M
YTE INCY:US $ 260.29M 132.62M